Found: 7
Select item for more details and to access through your institution.
Response to Aviv et al.
- Published in:
- 2021
- By:
- Publication type:
- editorial
Initial antipyrine disposition in man is altered by propranolol.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 2, p. P34, doi. 10.1016/j.clpt.2003.11.128
- By:
- Publication type:
- Article
Recombinant factor VIIa reduces transfusion requirements in liver transplant patients with high MELD scores.
- Published in:
- Transfusion Medicine, 2006, v. 16, n. 2, p. 93, doi. 10.1111/j.1365-3148.2006.00653.x
- By:
- Publication type:
- Article
Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 11, p. 2188, doi. 10.1038/leu.2014.122
- By:
- Publication type:
- Article
Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia.
- Published in:
- Leukemia (08876924), 2007, v. 21, n. 12, p. 2406, doi. 10.1038/sj.leu.2404975
- By:
- Publication type:
- Article
EPCORITAMAB MONOTHERAPY AND COMBINATIONS IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA OR RICHTER'S SYNDROME: NEW ESCALATION AND EXPANSION COHORTS IN EPCORE CLL‐1.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 828, doi. 10.1002/hon.3166_OT10
- By:
- Publication type:
- Article
THE CLL‐RT1 TRIAL: A MULTICENTER PHASE‐2 TRIAL OF ZANUBRUTINIB, A BTK INHIBITOR, PLUS TISLELIZUMAB, A PD‐1 INHIBITOR, FOR PATIENTS WITH RICHTER TRANSFORMATION.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.161_2880
- By:
- Publication type:
- Article